PlainRecalls
FDA Devices Moderate Class II Terminated

Randox Liquid Cardiac Controls Catalogue Number CQ5051

Reported: November 27, 2019 Initiated: October 4, 2019 #Z-0412-2020

Product Description

Randox Liquid Cardiac Controls Catalogue Number CQ5051

Reason for Recall

Removal of claims for N-proBNP in the Liquid Cardiac Control model numbers CQ5051 due to an observed decrease in recovery for N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in recent lots.

Details

Units Affected
6,208
Distribution
US Distribution: WV, CA, DE, NJ, NY, GA, IN, PR OUS Distribution: CA, PL, CH, JP, NL, IT, CN, GB, IE, RU, MD, BY, SA, VN, AE, BH, DK, CO, ES, FR, TW, PH, TH, OM, HU, IN, KR, ZA, AU, CZ, PE, CL, IR, NZ, BE, DE, BA, SV, SK, HK, PT, PK, BR, TR, UA, SE, QA, LT, PE,
Location
Crumlin, N/A

Frequently Asked Questions

What product was recalled?
Randox Liquid Cardiac Controls Catalogue Number CQ5051. Recalled by Randox Laboratories, Limited. Units affected: 6,208.
Why was this product recalled?
Removal of claims for N-proBNP in the Liquid Cardiac Control model numbers CQ5051 due to an observed decrease in recovery for N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in recent lots.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 27, 2019. Severity: Moderate. Recall number: Z-0412-2020.